Advertisement
Salem Radio Network News Saturday, February 24, 2018

Health

U.S. FDA approves AstraZeneca’s asthma drug

(Reuters) – Anglo-Swedish pharmaceutical firm AstraZeneca Plc on Tuesday said the U.S. Food and Drug Administration approved its drug benralizumab, as an add-on treatment for patients with severe asthma aged 12 years and older.

The asthma drug will be marketed under the name Fasenra in the United States.

Fasenra is under regulatory review in the EU, Japan and several other countries, the company said.

Previous
Next
AdvertisementAdvertise with Us
Advertisement
Advertisement

Editorial Cartoons

View More » 151898582486276sxNgBS1S6T

Michael Ramirez
Sat, Feb 17, 2018

Advertisement
Advertisement
Advertisement
X CLOSE